✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Neuren Pharmaceuticals Limited

Common Name
Neuren Pharmaceuticals
Country
Australia
Sector
Healthcare
Industry
Biotechnology
Employees
N/A
Ticker
NEU
Exchange
Australian Securities Exchange
Description
Neuren Pharmaceuticals Limited is a biopharmaceutical company specializing in the development of novel therapies for neurodevelopmental disorders that typically emerge in early childhood. Headquartere...

Neuren Pharmaceuticals's Revenues Data

Explore Neuren Pharmaceuticals's total revenue by fiscal year, normalized to USD alongside the as-reported original currency value.

Metric20252024
Total Revenue(USD)
43,225,927a
A$64,634,000
132,231,989a
A$213,243,000
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind Neuren Pharmaceuticals’s Revenues Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Neuren Pharmaceuticals's Annual Report 2025